New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 21, 2012
08:02 EDTNEPTNeptune Technologies files for revokation of Aker's Australian patents
Neptune Technologies and Bioressources announces that it has filed for the revocation of all of Aker Biomarine ASA's Australian patents before the Federal Court. More specifically, Neptune is seeking a declaration that all the claims in Aker's patents, namely the standard patent No. 2008231570 and the innovation patents Nos. 2012101332, 2012101333, 2012101334 and are, and at all materials times have been, invalid. The Aker Patents claim a krill oil composition and methods of extraction that lack novelty and are not patentable inventions. Neptune marketed its NKO krill oil product many years before Aker filed for these patents in Australia.
News For NEPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 23, 2015
19:10 EDTNEPTNeptune, Acasti announce USPTO decision that triggers royalty payments
Neptune Technologies & Bioressources (NEPT) and Acasti Pharma (ACST) announced that the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office, or USPTO, issued a favorable decision, confirming the validity of certain claims in Neptune's '351 patent and triggering royalty payments to Neptune. "This is a significant milestone that triggers the payment of ongoing royalties to Neptune by Aker and Enzymotec, based on their sales of licensed krill oil products in the US," said Neptuine CEO Jim Hamilton.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use